JP Morgan Chase’s Radius Health, Inc. RDUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-233,851
| Closed | -$2.42M | – | 7160 |
|
|
2022
Q2 | $2.42M | Buy |
233,851
+40,840
| +21% | +$304K | ﹤0.01% | 3388 |
|
|
2022
Q1 | $1.7M | Buy |
193,011
+151,090
| +360% | +$1.15M | ﹤0.01% | 3878 |
|
|
2021
Q4 | $290K | Buy |
41,921
+485
| +1% | +$7.12K | ﹤0.01% | 5154 |
|
|
2021
Q3 | $514K | Sell |
41,436
-1,556
| -4% | -$22.4K | ﹤0.01% | 4705 |
|
|
2021
Q2 | $785K | Buy |
42,992
+422
| +1% | +$8.39K | ﹤0.01% | 4435 |
|
|
2021
Q1 | $888K | Buy |
42,570
+7,530
| +21% | +$159K | ﹤0.01% | 4320 |
|
|
2020
Q4 | $626K | Buy |
35,040
+2,168
| +7% | +$32.6K | ﹤0.01% | 4248 |
|
|
2020
Q3 | $366K | Buy |
32,872
+372
| +1% | +$4.6K | ﹤0.01% | 4117 |
|
|
2020
Q2 | $443K | Sell |
32,500
-1,491
| -4% | -$20.5K | ﹤0.01% | 3906 |
|
|
2020
Q1 | $441K | Sell |
33,991
-1,973
| -5% | -$35.2K | ﹤0.01% | 3877 |
|
|
2019
Q4 | $725K | Sell |
35,964
-1,540
| -4% | -$37.4K | ﹤0.01% | 4051 |
|
|
2019
Q3 | $965K | Sell |
37,504
-4,263
| -10% | -$104K | ﹤0.01% | 3867 |
|
|
2019
Q2 | $993K | Buy |
41,767
+10,514
| +34% | +$230K | ﹤0.01% | 3879 |
|
|
2019
Q1 | $623K | Sell |
31,253
-203,796
| -87% | -$3.72M | ﹤0.01% | 4085 |
|
|
2018
Q4 | $3.88M | Buy |
235,049
+90,117
| +62% | +$1.52M | ﹤0.01% | 2772 |
|
|
2018
Q3 | $2.58M | Buy |
144,932
+26,655
| +23% | +$603K | ﹤0.01% | 3275 |
|
|
2018
Q2 | $3.48M | Buy |
118,277
+8,051
| +7% | +$254K | ﹤0.01% | 2972 |
|
|
2018
Q1 | $3.96M | Sell |
110,226
-7,277
| -6% | -$263K | ﹤0.01% | 2770 |
|
|
2017
Q4 | $3.73M | Buy |
117,503
+5,053
| +4% | +$159K | ﹤0.01% | 2910 |
|
|
2017
Q3 | $4.43M | Sell |
112,450
-8,104
| -7% | -$318K | ﹤0.01% | 2647 |
|
|
2017
Q2 | $5.45M | Sell |
120,554
-58,780
| -33% | -$2.25M | ﹤0.01% | 2418 |
|
|
2017
Q1 | $6.93M | Sell |
179,334
-76,317
| -30% | -$3.2M | ﹤0.01% | 2191 |
|
|
2016
Q4 | $9.72M | Sell |
255,651
-7,389
| -3% | -$352K | ﹤0.01% | 1929 |
|
|
2016
Q3 | $14.2M | Buy |
263,040
+62,605
| +31% | +$3.18M | ﹤0.01% | 1567 |
|
|
2016
Q2 | $7.37M | Buy |
200,435
+53,323
| +36% | +$1.88M | ﹤0.01% | 2036 |
|
|
2016
Q1 | $4.63M | Buy |
147,112
+65,259
| +80% | +$2.26M | ﹤0.01% | 2265 |
|
|
2015
Q4 | $5.04M | Buy |
81,853
+3,632
| +5% | +$229K | ﹤0.01% | 2223 |
|
|
2015
Q3 | $5.42M | Sell |
78,221
-30,430
| -28% | -$2.11M | ﹤0.01% | 2173 |
|
|
2015
Q2 | $7.36M | Sell |
108,651
-45,499
| -30% | -$2.12M | ﹤0.01% | 2141 |
|
|
2015
Q1 | $6.34M | Sell |
154,150
-25,675
| -14% | -$1.15M | ﹤0.01% | 2189 |
|
|
2014
Q4 | $7M | Sell |
179,825
-21,775
| -11% | -$516K | ﹤0.01% | 2186 |
|
|
2014
Q3 | $4.23M | Buy |
201,600
+1,600
| +0.8% | +$21.6K | ﹤0.01% | 2477 |
|
|
2014
Q2 | $2.6M | Buy |
+200,000
| New | +$1.85M | ﹤0.01% | 2397 |
|
Other funds holding RDUS
JP Morgan Chase's RDUS Position: Q3 2022 in Review
JP Morgan Chase sold out of Radius Health, Inc. (RDUS) in Q3 2022, closing a stake of 233,851 shares — an estimated $2.42M sold.
JP Morgan Chase first reported a position in RDUS in Q2 2014 and held it in 33 quarters. The position peaked at $14.2M in Q3 2016. 1 fund tracked by Wall St. Rank holds RDUS as of Q3 2022.
- JP Morgan Chase reported no remaining Radius Health, Inc. position as of Q3 2022 after selling out during the quarter.
- JP Morgan Chase sold 233,851 Radius Health, Inc. shares in Q3 2022, an estimated $2.42M.
- JP Morgan Chase first reported a position in Radius Health, Inc. in Q2 2014 and held it in 33 quarters.
- JP Morgan Chase's Radius Health, Inc. position peaked at $14.2M in Q3 2016.
- 1 fund tracked by Wall St. Rank held Radius Health, Inc. as of Q3 2022.
Based on JP Morgan Chase's 13F filing for Q3 2022, filed 14 Nov 2022.